TNNT1 and nemaline myopathy: Altogether, our findings suggest TnT remodelling as the key mechanism ultimately leading to molecular and cellular hyper‐contractility, and then inhibitors of altered contractility as potential therapeutic modalities for TNNT1‐associated NM.